Lung cancer among never-smokers is rising worldwide. In one U.S. study of 12,000 lung cancer patients, the share of people who didn’t smoke rose from 8 to 15 percent over twenty years.

French drugmaker Sanofi has halted the development of its antibody-drug conjugate (ADC) tusamitamab ravtansine after the drug failed a phase 3 trial in non-small cell lung cancer (NSCLC).

The FDA thinks an antibody-drug conjugate (ADC) developed by AbbVie could set new standards in treatment for certain patients with lung cancer, awarding the drug breakthrough status. Teliso-V ...

Don't let the placement of the characters on our Genshin Impact tier list deter you from pulling on the next character banner. Being on a lower tier in the free PC game means that there are better ...

Non-small-cell lung cancer (NSCLC) is the most common type of cancer affecting the lungs. The diverse types of NSCLC are characterized by cancer cells that grow and spread in different ways.

According to the CDC, there is no evidence that mold causes lung cancer or any other type of cancer. However, exposure to some types of mold can cause respiratory symptoms and aggravate asthma in ...

Exploring the impact of neutrophils on lung adenocarcinoma using Mendelian randomization and transcriptomic study Xiang Xiao Xuan-Yu Wu Jing Guo Research Open Access 03 Jul 2025 Scientific Reports ...